Family Medicine Doctors in Decatur, IN Accepting Medicare

9 Family Medicine doctors found. Showing 1 - 9

Dr. Ronald Orie Browne, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 Mercer Ave, Decatur, IN 46733 Phone: 260-724-2145

Dr. Keith A Harvey, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 955 High St, Ste 1, Decatur, IN 46733 Phone: 260-724-8551    Fax: 260-728-3858

Lisa Marie Ferrando, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1100 Mercer Ave, Decatur, IN 46733 Phone: 260-724-2145

Scott T Smith, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1100 Mercer Ave, Decatur, IN 46733 Phone: 260-724-2145

Jessamine A Hippensteel, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 815 High St, Suite C, Decatur, IN 46733 Phone: 260-728-3843    Fax: 260-728-3832

Mark S Gresla, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 955 High St, Suite 3, Decatur, IN 46733 Phone: 260-724-2125    Fax: 260-724-3859

Michael E Ainsworth, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 955 High St, Ste 2, Decatur, IN 46733 Phone: 260-724-8700    Fax: 260-728-3821

Cameron V Nelson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 955 High St, Ste 2, Decatur, IN 46733 Phone: 260-724-8700    Fax: 260-728-3821

Kathleen A. Heimann, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 Mercer Ave, Decatur, IN 46733 Phone: 260-724-2145    Fax: 260-728-3853

News Archive

BioMarin completes BMN 195 Phase 1 clinical trial for Duchenne muscular dystrophy

BioMarin Pharmaceutical Inc. announced today that it has completed the Phase 1 clinical study of BMN 195, a small molecule utrophin up-regulator, for the treatment of Duchenne muscular dystrophy (DMD). The Phase 1 clinical trial was a single-center, double-blind, placebo-controlled, single-dose escalation study followed by a multiple-dose escalation study in healthy volunteers.

Short people at greater risk of developing CVD or CHD compared to tall people: Review

Short people are at greater risk of developing heart disease than tall people, according to the first systematic review and meta-analysis of all the available evidence, which is published online today (Wednesday 9 June) in the European Heart Journal.

Federal Appeals Court agrees to rehear case on whether people should have access to experimental medications

The U.S. Court of Appeals for the District of Columbia on Tuesday vacated an earlier decision that would have provided terminally ill patients with expanded access to experimental medications and likely will rehear the case next summer, Dow Jones/Wall Street Journal reports (Wilde Mathews, Dow Jones/Wall Street Journal, 11/21).

Polaris Group reports positive results from ADI-PEG 20 Phase 2 trial for malignant pleural mesothelioma

Polaris Group announced today that positive results from a randomized Phase 2 trial of ADI-PEG 20, arginine deiminase formulated with polyethylene glycol, for the treatment of malignant pleural mesothelioma were presented at the World Conference on Lung Cancer in Sydney, Australia.

Read more Medical News

› Verified 8 days ago